| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Jan―22 |
Drug-drug interaction between ensitrelvir and tacrolimus in a patient undergoing treatment for COVID-19: a case report |
Yuki Miyata, Ryo Yamaguchi, Takehito Yamamoto, Toshiyuki Kishida, Kazuhiko Ikeuchi, Hiroaki Harada, et al. (+3) Takeya Tsutsumi, Keishi Fujio, Tappei Takada |
| 2 |
[GO] |
2025―Jan―08 |
Correction: Comparison of facilities with and without additional medical fees for nutrition support team activity during the COVID-19 pandemic |
Akihiko Futamura, Takenao Koseki, Junichi Iida, Akito Suzuki, Nobuyuki Muroi, Michiaki Myotoku, et al. (+6) Hiroki Maki, Kazuhisa Mizutani, Hikaru Ogino, Yasuki Taniguchi, Keiichiro Higashi, Masanobu Usui |
| 3 |
[GO] |
2024―Oct―31 |
Comparison of facilities with and without additional medical fees for nutrition support team activity during the COVID-19 pandemic |
Akihiko Futamura, Takenao Koseki, Junichi Iida, Akito Suzuki, Nobuyuki Muroi, Michiaki Myotoku, et al. (+6) Hiroki Maki, Kazuhisa Mizutani, Hikaru Ogino, Yasuki Taniguchi, Keiichiro Higashi, Masanobu Usui |
| 4 |
[GO] |
2024―Mar―04 |
Vaccination status, incidence of adverse events, and awareness of COVID-19 vaccine among outpatients undergoing chemotherapy |
Satoshi Iwakawa, Takuya Azechi, Orie Saigo, Ryunosuke Imai, Ayumi Nakai, Shoji Koshiba, et al. (+4) Uki Saito, Kota Asakura, Kuniyoshi Sato, Toshimi Kimura |
| 5 |
[GO] |
2022―Dec―07 |
Utilizing questionnaires for medication counselling of patients taking antipsychotics during the COVID-19 pandemic: a single site, community pharmacy-based survey study |
Masaki Maehara, Masayasu Sugiyama |
| 6 |
[GO] |
2022―Nov―01 |
Immune checkpoint inhibitor therapy and elevated levels of C-reactive protein associated with COVID-19 aggravation in patients with lung cancer |
Masatoshi Maki, Ryo Takada, Akihiko Taniguchi, Naoyuki Nomura, Seiichiro Kuramoto, Yuki Chiko, et al. (+3) Toshiaki Okada, Seiji Saito, Koji Tamura |
| 7 |
[GO] |
2022―Jan―03 |
Casirivimab-imdevimab neutralizing SARS-CoV-2: post-infusion clinical events and their risk factors |
Junichi Yoshida, Kenichiro Shiraishi, Tetsuro Tamura, Kazuhiro Otani, Tetsuya Kikuchi, Akiko Mataga, et al. (+2) Takako Ueno, Masao Tanaka |
| 8 |
[GO] |
2021―Apr―01 |
Impact of a clinical pharmacist on ultrasound-guided venous thromboembolism screening in hospitalized COVID-19 patients: a pilot prospective study |
Laura Gillespie, Rashid Z. Khan, John E. Stillson, Connor M. Bunch, Faisal Salim Shariff, Jacob Speybroeck, et al. (+9) Anne Grisoli, Meredith Wierman Schmidt, Htay Phyu, Jason Jablonski, Byars Wells, Daniel H. Fulkerson, Lyndsay Oancea, Abraham Leiser, Mark Walsh |
|
